Package Insert: Information for the User
Roasax 5 mg/100 mg Hard Capsules
rosuvastatina/acid acetilsalicilic
Read this package insert carefully before you start taking this medicine, because it contains important information for you.
Roasax contains two active principles rosuvastatina and acetylsalicylic acid.
These two active substances, taken together, reduce the likelihood of having another heart attack if you have previously had a heart attack or if you suffer from unstable chest pain (angina pectoris).Roasaxis indicated in patients who are already taking rosuvastatina and acetylsalicylic acid at these doses. Instead of taking rosuvastatina and acetylsalicylic acid in separate tablets, you will receive a capsule ofRoasaxthat contains both ingredients with the same dose as before.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Roasax:
You should see your doctor immediately if your symptoms worsen or if you experience severe or unexpected side effects, for example, unusual bleeding symptoms, severe skin reactions, or any other sign of severe allergy (see section "Possible side effects").
Metamizol (a substance to reduce pain and fever) may reduce the effect of acetylsalicylic acid on platelet aggregation (blood cells stick together and form a blood clot), when taken concomitantly. Therefore, this combination should be used with caution in patients taking aspirin in low doses for cardioprotection.
In a reduced number of people, statins may affect the liver. This is detected by a simple test that detects increased levels of liver enzymes in the blood. For this reason, your doctor will usually perform blood tests (liver function test) before and after treatment with Roasax.
While taking this medication, your doctor will closely monitor you if you have diabetes or are at risk of developing diabetes. You may be at risk of developing diabetes if you have high blood sugar and lipid levels, are overweight, and have high blood pressure.
You should be careful not to become dehydrated (you may feel thirsty with a dry mouth), as the use of acetylsalicylic acid at the same time may cause deterioration of renal function.
Inform your doctor if you are planning to undergo surgery (even a small one, such as tooth extraction), as acetylsalicylic acid thins the blood, increasing the risk of bleeding.
Acetylsalicylic acid may cause Reye's syndrome when administered to children. Reye's syndrome is a rare disease that affects the brain and liver and can be potentially fatal. For this reason, Roasax should not be administered to children and adolescents under 18 years old.
In patients with severe glucose-6-phosphate dehydrogenase deficiency: acetylsalicylic acid may cause rapid collapse or red blood cell collapse or a certain type of anemia. This risk may be caused by factors such as high doses, fever, or acute infections that may increase.
Acetylsalicylic acid reduces uric acid excretion in low doses. This may trigger a gout attack in patients at risk.
If you cut or injure yourself, bleeding may be slightly longer than usual. This is related to the effect of acetylsalicylic acid. Small cuts and injuries (for example, when shaving) are usually not significant. If you have unusual bleeding (in an unusual place or of unusual duration), contact your doctor.
Severe skin reactions, including Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported associated with rosuvastatin treatment. Stop using Roasax and seek medical attention immediately if you notice any of the symptoms described in section 4.
Medications containing acetylsalicylic acid should not be taken for prolonged periods or in high doses without consulting a doctor.
Children and adolescents
Roasax should not be used in children and adolescents.
Other medications and Roasax
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Roasax may affect or be affected by other medications such as:
If you need to take ácido fusídico orally to treat a bacterial infection, you should temporarily stop using Roasax. Your doctor will indicate when it is safe to resume taking this medication. Taking Roasax with ácido fusídico rarely may cause muscle weakness, sensitivity, or pain (rabdomiólisis). See more information about rabdomiólisis in section 4.
Taking Roasax with food and drinks
Drinking alcohol may increase the risk of gastrointestinal bleeding and prolong bleeding time.
Pregnancy and breastfeeding
Do not take Roasax if you are pregnant or breastfeeding. If you become pregnant while taking Roasax, stop taking it immediately and inform your doctor. Women should avoid becoming pregnant during treatment with this medication using an appropriate contraceptive method.
Driving and operating machinery
Most patients can drive vehicles and use machinery during treatment with Roasax as it will not affect their ability. However, some people may feel dizzy during treatment with this medication. If you feel sick, dizzy, or tired, or have a headache, do not drive or use machinery and consult your doctor immediately.
Roasax contains lactose
This medication contains lactose. If your doctor has told you that you have a certain sugar intolerance, consult with him before taking this medication.
Roasax contains soy oil
This medication contains soy oil. It should not be used in case of an allergy to peanuts or soy.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Adults
Your doctor will establish the most suitable dose for you, depending on your condition, current treatment, and personal risk.
This medication is not suitable for starting treatment. Treatment initiation should only be done by administering the active principles separately and after adjusting the appropriate doses, it will be possible to switch toRoasaxat the appropriate concentration.
The recommended dose is one capsule per day.
This medication should be taken with food. You should take your medication at the same time every day. Capsules should be swallowed with plenty of liquid and should not be crushed or chewed.
If you are admitted to a hospital or receive treatment for another condition, inform the medical staff that you are takingRoasax.
Older patients
No dose adjustment is necessary for older patients.
Children and adolescents
Roasaxshould not be used in children and adolescents.
Patients with renal insufficiency
No dose adjustment is necessary if you have mild or moderate renal insufficiency.
The use of Roasax in patients with severe renal insufficiency is contraindicated.
Patients with hepatic insufficiency
The use of Roasax in patients with severe hepatic insufficiency is contraindicated.
If you take more Roasax than you should
Contact your doctor or nearest hospital for advice. You can also call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Roasax
Do not worry. If you forget to take a capsule, omit that dose completely. Take the next scheduled dose at the usual time. Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Roasax
Your doctor will advise you for how long you should take your medication. Your cholesterol levels may increase again if you stop taking Roasax. Your condition may recur if you stop using your medication before it is indicated.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Stop taking Roasax and see your doctorimmediatelyif you experience any of the following rare and serious side effects after taking this medicine.
Also, stop takingRoasaxand talk to your doctor immediately
The followingside effects have been reported. If any of these cause you problems or ifthey last more than a week, you shouldcontact your doctor.
ROSUVASTATINA
Common(can affect up to 1 in 10 people):
Uncommon(can affect up to 1 in 100 people):
Rare(can affect up to 1 in 1,000 people):
Very rare(can affect up to 1 in 10,000 people):
Frequency not known(the frequency cannot be estimated from the available data):
See your doctor if you experience weakness in your arms or legs that worsens after periods of activity, double vision, eyelid drooping, difficulty swallowing, or difficulty breathing.
ACID ACETILSALICILICO
Common(can affect up to 1 in 10 people):
Uncommon(can affect up to 1 in 100 people):
Rare(can affect up to 1 in 1,000 people):
Very rare(can affect up to 1 in 10,000 people):
Frequency not known(the frequency cannot be estimated from the available data):
-Accelerated degradation or decomposition of red blood cells and a specific form of anemia in patients with severe glucose-6-phosphate dehydrogenase deficiency.
- In the case of previous mucosal damage, membranes may form in the intestinal cavity with possible subsequent narrowing.
If you consider that any of the side effects you are experiencing is severe or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist.
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Store below 30°C. Store in the original packaging protected from moisture.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE point of your pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
The active principles are rosuvastatina (as rosuvastatina calcium) and acetic acid salicylic.
Roasax 5 mg/100 mg: each hard capsule contains 5 mg of rosuvastatina (as rosuvastatina calcium) and 100 mg of acetic acid salicylic.
The other components are:
Coated tablet with rosuvastatina:
Core
Lactose monohydrate
Microcrystalline cellulose
Heavy magnesium oxide
Crospovidone (type A)
Anhydrous colloidal silica
Magnesium stearate
Covering
Polivinyl alcohol
Titanium dioxide (E171)
Talc
Yellow iron oxide (E172)
Soy lecithin
Red iron oxide (E172)
Xanthan gum
Black iron oxide (E172)
Tablet with acetic acid salicylic:
Microcrystalline cellulose
Maize starch
Anhydrous colloidal silica
Stearic acid
Capsule coating:
Gelatin
Titanium dioxide (E171)
Indigotin (E132)
Yellow iron oxide (E172)
Black ink:
Shellac
Propylene glycol
Strong ammonia solution
Black iron oxide (E172)
Potassium hydroxide
Appearance of the product and contents of the package
Roasax 5 mg/100 mg: hard gelatin capsules of size 2 and opaque white body and opaque dark green cap. Each capsule contains a white or almost white, biconvex, oval-shaped, uncoated tablet of acetic acid salicylic and a brown, biconvex, round, coated tablet with 5 mg of rosuvastatina.
Roasax is presented in blisters containing 10, 28, 30, 56, 60, 90 and 100 hard capsules.
Only some package sizes may be marketed.
Marketing authorization holder and manufacturer responsible
Marketing authorization holder
Adamed Laboratorios, S.L.U.
c/ de las Rosas de Aravaca, 31
2nd floor
28023 - Madrid
Manufacturer responsible
Adamed Pharma S.A.
ul. Marszalka Józefa Pilsudskiego 5
95-200 Pabianice
Poland
or
IASIS PHARMACEUTICALS HELLAS S.A.
137 Filis Ave., Kamatero
13451 Athens
Greece
or
BELUPO D.D.
Ulica Danica 5
48000 Koprivnica
Republic of Croatia
or
Genericon Pharma Gesellschaft m.b.H.
Hafnerstrasse 211, 8054 Graz
Austria
This medicinal product is authorized in the member states of the European Economic Area with the following names:
Poland: Rosuvastatin+Acetylsalicylic acid Adamed
Austria: RosuASS 5 mg/100 mg Hartkapseln
Bulgaria: ????????????/???????????????? ???????? Adamed
Spain: Roasax 5 mg/100 mg hard capsules
Germany: RosuASS APONTIS, 5 mg/100 mg Hartkapseln
Cyprus: ROSU-ASA
Greece: ROSU-ASA
Croatia: ROSIX DUO 5 mg/100 mg tvrde kapsule
Slovenia: BELOROSTIN 5 mg/100 mg trde kapsule
Portugal: ESTASP
Italy: ASADROX
Last review date of this leaflet: April 2025
The detailed and updated information of this medicinal product is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.